Current Pharmacogenomics and Personalized Medicine
Title:Editorial [Rethinking Pharmacogenomics in an Ecosystem: Drug-microbiome Interactions, Pharmacomicrobiomics, and Personalized Medicine for the Human Supraorganism]
Volume: 10 Issue: 4
Author(s): Ramy K. Aziz
Affiliation:
Keywords: Drug-microbiome interaction, microbiota, normal flora, pharmacomicrobiomics, pharmacometabolomics, pharmacometabonomics, public health pharmacogenomics, systems pharmacology.
Export Options
About this article
Cite this article as:
Aziz K. Ramy, Editorial [Rethinking Pharmacogenomics in an Ecosystem: Drug-microbiome Interactions, Pharmacomicrobiomics, and Personalized Medicine for the Human Supraorganism], Current Pharmacogenomics and Personalized Medicine 2012; 10 (4) . https://dx.doi.org/10.2174/187569212803901710
DOI https://dx.doi.org/10.2174/187569212803901710 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New and Emerging Antiresorptive Treatments in Osteoporosis
Current Drug Safety Bupropion in the Depression-Related Sexual Dysfunction: A Systematic Review
CNS & Neurological Disorders - Drug Targets Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa
Recent Patents on Nanomedicine GnRH-Agonist Triggering to Avoid Ovarian Hyperstimulation Syndrome: A Review of the Evidence
Current Drug Targets The Clinical Perspective on Value of 3D, Thin Slice T2-Weighted Images in 3T Pelvic MRI for Tumors
Current Medical Imaging Osteoporosis in Patients with Breast and Prostate Cancer: Effect of Disease and Treatment Modalities
Endocrine, Metabolic & Immune Disorders - Drug Targets The Effects of the Endocrine Disruptors Dithiocarbamates on the Mammalian Ovary with Particular Regard to Mancozeb
Current Pharmaceutical Design Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis
Current Medicinal Chemistry Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical Research
Current Medicinal Chemistry Emerging Therapeutic Agents for Cervical Cancer
Recent Patents on Anti-Cancer Drug Discovery Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review
Current Drug Targets Predictors and Clinical Implications of HPV Reservoire Districts for Genital Tract Disease
Current Pharmaceutical Design Metabolism and Toxicological Implications of Commonly Used Chemopreventive Drugs Against Breast Cancer/Carcinogenesis
Current Drug Metabolism Detection of Residual/Recurrent Cervical Disease after Successful LEEP Conization: the Possible Role of mRNA-HPV Test
Current Pharmaceutical Design HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies
Current Pharmaceutical Design Oral HPV Infection: Current Strategies for Prevention and Therapy
Current Pharmaceutical Design Toll-Like Receptors in the Cycling Female Reproductive Tract and During Pregnancy
Current Women`s Health Reviews Self-Emulsifying Drug Delivery System (SEDDS) and its Pharmaceutical Applications
Applied Clinical Research, Clinical Trials and Regulatory Affairs Iontophoresis: Drug Delivery System by Applying an Electrical Potential Across the Skin
Drug Delivery Letters Anti-Candida Activity of Essential Oils
Mini-Reviews in Medicinal Chemistry